Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00694642
Recruitment Status : Completed
First Posted : June 10, 2008
Last Update Posted : August 6, 2013
Fundación Mutua Madrileña
Information provided by (Responsible Party):
Pilar Jimenez Quevedo, Hospital San Carlos, Madrid

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2009
  Study Completion Date : February 2012